MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 67.25 EUR 0.37%
Market Cap: 2.5B EUR
Have any thoughts about
MorphoSys AG?
Write Note

EV/OCF
Enterprise Value to OCF

-7.2
Current
-1.4
Median
5.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-7.2
=
Enterprise Value
2.2B EUR
/
Operating Cash Flow
-298.2m EUR
All Countries
Close
Market Cap EV/OCF
DE
MorphoSys AG
XETRA:MOR
2.5B EUR -7.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 691.7
US
Abbvie Inc
NYSE:ABBV
314.9B USD 22.2
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 26
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD -114.2
US
Epizyme Inc
F:EPE
94.1B EUR -469.8
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 16.6
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36B EUR -132.6
 
DE
MorphoSys AG
XETRA:MOR
Average EV/OCF: 22
Negative Multiple: -7.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 691.7
US
Abbvie Inc
NYSE:ABBV
22.2
US
Amgen Inc
NASDAQ:AMGN
26
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.8
AU
CSL Ltd
ASX:CSL
34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.6

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More